# Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia

> **NCT07715669** · EARLY_PHASE1 · RECRUITING · sponsor: **Anna Stanhewicz, PhD** · enrollment: 40 (estimated)

## Conditions studied

- Preeclampsia
- Endothelial Function

## Interventions

- **DRUG:** Paroxetine Hydrochloride
- **DRUG:** Ascorbic acid (Vitamin C)

## Key facts

- **NCT ID:** NCT07715669
- **Lead sponsor:** Anna Stanhewicz, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-30
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715669, "Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07715669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*